Literature DB >> 222463

Evolution of multiple genome mutations during long-term persistent infection by vesicular stomatitis virus.

J J Holland, E A Grabau, C L Jones, B L Semler.   

Abstract

Persistent infection of BHK21 cells was established with cloned vesicular somatitis virus plus purified Dl particles and maintained in vitro for over 5 years. After 1 year of persistence, the infectious virus RNA genome had evolved several oligonucleotide map changes, and numerous changes had accumulated by 3.5 years. Additional evolution occurred by the fourth year and continued until the fifth year. In contrast, repeated passage of virus in acute infections of several cell types in vitro or in vivo did not lead to detectable oligonucleotide map changes. The short Dl particle originally used to co-infect with infectious virus in establishing persistent infection has been displaced by an ever present and constantly changing population of other Dl particles of differing sizes and radically differing oligonucleotide maps. We conclude that the genomes of both infectious VSV and its Dl particles undergo continuous evolutionary change during years of persistence. In the infectious virus, these changes involve hundreds of mutations which are usually expressed as poorly replicating, temperature-sensitive, small plaque mutants. These are stable mutants which do not revert to wild-type when passaged repeatedly in acute infections at 37 or 33 degrees C. It appears that the sequestered intracellular environment of persistently infected cells favors rapid and continuous virus evolution.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222463     DOI: 10.1016/0092-8674(79)90024-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  50 in total

1.  Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells.

Authors:  S C Weaver; A C Brault; W Kang; J J Holland
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Persistent vesicular stomatitis virus infection mediates base substitutions in viral RNA termini.

Authors:  B L Semler; J J Holland
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

3.  Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses.

Authors:  J J Holland; J C de la Torre; D K Clarke; E Duarte
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  RNA virus quasispecies populations can suppress vastly superior mutant progeny.

Authors:  J C de la Torre; J J Holland
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Polymerase errors accumulating during natural evolution of the glycoprotein gene of vesicular stomatitis virus Indiana serotype isolates.

Authors:  P A Bilsel; S T Nichol
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus.

Authors:  H Sheshberadaran; E Norrby; K W Rammohan
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

7.  Effects of antibodies and interferon on mumps virus persistently infected L929 cells. Generation of variant viruses in the cells during incubation with monoclonal antibodies and interferon.

Authors:  Y Ito; M Tsurudome; M Hishiyama
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Persistent infection of a temperature-sensitive G31 vesicular stomatitis virus mutant in neural and nonneural cells: biological and virological characteristics.

Authors:  J Huprikar; S G Rabinowitz; M C DalCanto; M K Rundell
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

9.  In memoriam John J. Holland (1929-2013): a pioneer in molecular virology.

Authors:  Katherine R Spindler; Bert L Semler
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

10.  Novel phenotype of RNA synthesis expressed by vesicular stomatitis virus isolated from persistent infection.

Authors:  T K Frey; J S Youngner
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.